Sasol Limited (SASOF)

Elevation Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	3,154	4,808	7,855	14,282	9,591	4,776
Market Cap Growth	-56.53%	-38.79%	-45.00%	48.91%	100.84%	-69.04%
Enterprise Value	8,788	10,583	13,004	20,444	18,051	13,360
Last Close Price	4.94	7.50	12.60	22.51	15.15	7.76
PE Ratio	-	-	16.82	6.00	15.16	-
PS Ratio	0.23	0.32	0.51	0.86	0.68	0.44
PB Ratio	0.39	0.60	0.73	1.21	0.90	0.53
P/TBV Ratio	0.41	0.63	0.76	1.26	0.95	0.56
P/FCF Ratio	4.54	12.01	8.02	13.63	7.73	-
P/OCF Ratio	1.41	2.35	3.01	5.80	4.02	2.78
EV/Sales Ratio	0.61	0.70	0.85	1.23	1.28	1.22
EV/EBITDA Ratio	2.86	3.34	3.56	5.19	5.95	6.51
EV/EBIT Ratio	3.95	4.33	4.56	6.64	10.05	17.41
EV/FCF Ratio	12.66	26.43	13.28	19.51	14.54	-
Debt / Equity Ratio	0.88	0.92	0.70	0.63	0.78	1.33
Debt / EBITDA Ratio	2.44	2.24	1.98	1.88	2.74	5.83
Debt / FCF Ratio	10.24	18.49	7.62	7.06	6.70	-
Asset Turnover	0.66	0.69	0.68	0.70	0.48	0.41
Inventory Turnover	3.27	3.70	4.02	3.88	3.39	3.50
Quick Ratio	1.11	1.52	0.87	0.96	1.07	0.68
Current Ratio	1.84	2.33	1.32	1.44	1.83	1.91
Return on Equity (ROE)	-27.46%	-25.36%	4.73%	24.11%	6.83%	-48.50%
Return on Assets (ROA)	6.24%	6.99%	7.87%	8.07%	3.84%	1.77%
Return on Capital (ROIC)	7.88%	8.94%	10.22%	10.76%	5.05%	2.30%
Return on Capital Employed (ROCE)	13.10%	14.40%	16.20%	15.40%	8.50%	3.50%
Earnings Yield	-82.70%	-50.44%	5.95%	16.66%	6.60%	-110.74%
FCF Yield	22.01%	8.33%	12.47%	7.34%	12.94%	-6.50%
Dividend Yield	-	1.46%	7.16%	3.99%	-	-
Payout Ratio	-	-	156.31%	0.13%	0.51%	-
Buyback Yield / Dilution	8.58%	4.37%	-4.25%	-1.13%	-1.60%	0.39%
Total Shareholder Return	-	5.83%	2.91%	2.86%	-1.60%	0.39%

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.